DE-110 Ophthalmic Suspension

DE-110 · Santen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-110 Ophthalmic Suspension, covering 2014-05-21 to 2014-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease [Phase 2]